Literature DB >> 1920429

Refined atomic structures of N9 subtype influenza virus neuraminidase and escape mutants.

W R Tulip1, J N Varghese, A T Baker, A van Donkelaar, W G Laver, R G Webster, P M Colman.   

Abstract

The crystal structure of the N9 subtype neuraminidase of influenza virus was refined by simulated annealing and conventional techniques to an R-factor of 0.172 for data in the resolution range 6.0 to 2.2 A. The r.m.s. deviation from ideal values of bond lengths is 0.014 A. The structure is similar to that of N2 subtype neuraminidase both in secondary structure elements and in their connections. The three-dimensional structures of several escape mutants of neuraminidase, selected with antineuraminidase monoclonal antibodies, are also reported. In every case, structural changes associated with the point mutation are confined to the mutation site or to residues that are spatially immediately adjacent to it. The failure of antisera to cross-react between N2 and N9 subtypes may be correlated with the absence of conserved, contiguous surface structures of area 700 A2 or more.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1920429     DOI: 10.1016/0022-2836(91)80069-7

Source DB:  PubMed          Journal:  J Mol Biol        ISSN: 0022-2836            Impact factor:   5.469


  23 in total

1.  Structural evidence for a second sialic acid binding site in avian influenza virus neuraminidases.

Authors:  J N Varghese; P M Colman; A van Donkelaar; T J Blick; A Sahasrabudhe; J L McKimm-Breschkin
Journal:  Proc Natl Acad Sci U S A       Date:  1997-10-28       Impact factor: 11.205

2.  Epitope analysis for influenza vaccine design.

Authors:  Enrique T Muñoz; Michael W Deem
Journal:  Vaccine       Date:  2005-01-19       Impact factor: 3.641

3.  Crystallization of biologically active hemagglutinin-neuraminidase glycoprotein dimers proteolytically cleaved from human parainfluenza virus type 1.

Authors:  T Takimoto; W G Laver; K G Murti; A Portner
Journal:  J Virol       Date:  1992-12       Impact factor: 5.103

4.  Generation and characterization of variants of NWS/G70C influenza virus after in vitro passage in 4-amino-Neu5Ac2en and 4-guanidino-Neu5Ac2en.

Authors:  J L McKimm-Breschkin; T J Blick; A Sahasrabudhe; T Tiong; D Marshall; G J Hart; R C Bethell; C R Penn
Journal:  Antimicrob Agents Chemother       Date:  1996-01       Impact factor: 5.191

5.  A single amino acid alteration in the human parainfluenza virus type 3 hemagglutinin-neuraminidase glycoprotein confers resistance to the inhibitory effects of zanamivir on receptor binding and neuraminidase activity.

Authors:  M T Murrell; M Porotto; O Greengard; N Poltoratskaia; A Moscona
Journal:  J Virol       Date:  2001-07       Impact factor: 5.103

6.  Binding affinity of influenza virus N9 neuraminidase with Fab fragments of monoclonal antibodies NC10 and NC41.

Authors:  L C Gruen; T L McInerney; R G Webster; D C Jackson
Journal:  J Protein Chem       Date:  1993-06

7.  Sequence and structure alignment of paramyxovirus hemagglutinin-neuraminidase with influenza virus neuraminidase.

Authors:  P M Colman; P A Hoyne; M C Lawrence
Journal:  J Virol       Date:  1993-06       Impact factor: 5.103

8.  Crystal structure of a bacterial sialidase (from Salmonella typhimurium LT2) shows the same fold as an influenza virus neuraminidase.

Authors:  S J Crennell; E F Garman; W G Laver; E R Vimr; G L Taylor
Journal:  Proc Natl Acad Sci U S A       Date:  1993-11-01       Impact factor: 11.205

9.  Three-dimensional structure of the complex of 4-guanidino-Neu5Ac2en and influenza virus neuraminidase.

Authors:  J N Varghese; V C Epa; P M Colman
Journal:  Protein Sci       Date:  1995-06       Impact factor: 6.725

10.  Antigenicity of the N8 influenza A virus neuraminidase: existence of an epitope at the subunit interface of the neuraminidase.

Authors:  T Saito; G Taylor; W G Laver; Y Kawaoka; R G Webster
Journal:  J Virol       Date:  1994-03       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.